The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses

By D. Boone, Emre E. Turer, Eric G. Lee, Regina-Celeste Ahmad, M. Wheeler, C. Tsui, P. Hurley, Marcia Chien, Sophia Chai, O. Hitotsumatsu and 3 more. Nature Immunology, 2004

1,168 citations recorded by the source corpus.

Subfields: Cancer Research, Immunology

View Paper: https://www.semanticscholar.org/paper/b2d99efe55da5f9d9a5e796ec8747cc83b4a2953

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

  1. S. Ghosh
  2. M. Hayden
  3. Shizuo Akira
  4. M. Karin
  5. T. Mogensen
  6. N. Perkins
  7. Luke A. O'Neill
  8. T. Lawrence

In Immunology

  1. Shizuo Akira
  2. S. Ghosh
  3. M. Hayden
  4. M. Karin
  5. O. Takeuchi
  6. T. Mogensen
  7. R. Medzhitov
  8. K. Honda

Citations in the corpus